Document is current
Any future updates will be listed below
-
Authors
Houston, Andrew
Williams, Sophie
Ricketts, William
Gutteridge, Charles
Tackaberry, Chris
Conibear, John
-
Funding
Funding for this research was provided by:
AstraZeneca
- License Information
-
More Information
Article History
Received: 9 January 2024
Accepted: 27 November 2024
First Online: 4 December 2024
Declarations
:
: This study was submitted to an NHS Research Ethics Committee, with subsequent approval being granted by the NHS Health Research Authority (IRAS ID: 320934). The requirement for informed consent to participate was waived by the NHS Health Research Authority following support, granted by the NHS Confidentiality Advisory Group, under Sect. 251 of the National Health Service Act 2006. The study also adhered to the NHS National Data Opt-Out to respect patients’ decision to opt out of the use of their data for research purposes.
: Not applicable.
: C.T. is a Director, employee and shareholder at Clinithink Ltd., the entity that owns the NLP software employed for extracting clinical features from the free-text in this study. The remaining authors declare that they have no competing interests.
